A premium integrative support system. DNA science, global standards 2026.
We integrate the pharmacodynamics of Amazonian endemics into modern oncology protocols, aligning therapy with the biochemical standards of 2026.
Targeted therapy and next-generation immunotherapy.
Precision radiotherapy and combination protocols.
Bispecific antibodies and high-tech oncology.
Works like a cooling radiator in an overheated system: active compounds neutralize reactive oxygen species (ROS), preventing structural DNA damage and reducing the risk of secondary mutations in healthy tissues within the oxidative-stress zone.
Suppresses the cascade of pro-inflammatory cytokines — in a mechanical analogy, a firm shut-off of the resource valves feeding the microenvironment that gives the tumor node a background for aggressive proliferation.
Enhances the phagocytic activity of macrophages — like a signature update for the body's internal “security scanner”, increasing the immune system's sensitivity to recognizing hidden tumor antigens.
Pro-apoptotic direction: a preclinical research focus on how the compounds interact with inflammatory mediators and regulated cell-death pathways, including ferroptosis. Laboratory stage — not a proven clinical effect.
Angiostasis: a studied hypothesis about influence on vascular growth signals in model systems, as part of tumor-microenvironment research. Human data remain insufficient.
Metabolic balance: an in-vitro hypothesis about shifting cellular energy metabolism and supporting mitochondrial potential. Requires further verification.
Anti-invasive direction: preclinical investigation of cell-motility and invasion mechanisms. Translation to patients is not established.
Endothelial stability: laboratory-model study of potential support for the vascular wall. Not a promise of prevention or treatment.
Epigenetic modulation: a preclinical-level hypothesis about influencing the differentiated cell phenotype.
Ancestors is three-stage support intended as a complement to the standard of care, not a replacement. The points above describe directions of preclinical (laboratory) research and hypotheses — not proven clinical effects — and do not replace medical advice.
An activator of the mitochondrial resource — the core of the ritual.
Read more +The core of the system: an activator of the mitochondrial resource. In preclinical (laboratory) study it is explored for supporting cellular energy balance and antioxidant defense — directions of research, not proven clinical effects. A complement to the standard of care, not a replacement.
Three-stage support tuned to your state and goals.
Read more +Three-stage support tuned to your state and goals. Studied in preclinical research across pro-apoptotic, metabolic and anti-invasive directions — directions and hypotheses, not proven clinical effects. A complement to the standard of care, not a replacement.
Quantum activation of molecules under specialist supervision.
Read more +Quantum activation of molecules under specialist supervision. At 660 nm, red light is used to help the components of our complexes penetrate deeper into the tissues. Applied as a complement to the standard of care, under specialist supervision.
A specialist will contact you and help build your profile.
Your data is not stored as individual records — it is used only for the review; your information stays private and secure.